期刊文献+

观察阿托伐他汀治疗老年高血压患者动脉硬化的临床效果及特点 被引量:1

Objective To Observe the Clinical Efficacy and Characteristics of Atorvastatin in the Treatment of Arteriosclerosis in Elderly Hypertensive Patients
下载PDF
导出
摘要 目的对阿托伐他汀治疗老年高血压患者动脉硬化的临床效果及特点进行观察分析。方法回顾性分析本院2015年6月-2016年6月期间收治的160例高血压动脉硬化患者的临床资料,并随机分为观察组和对照组,采用常规治疗的80例患者分为对照组,采用常规治疗加以阿托伐他汀治疗的80例患者分为观察组,对两组的治疗效果进行对比分析。结果治疗后观察组患者治疗的总有效率明显比对照组高(P<0.05),血压改善情况显著优于对照组(P<0.05)。结论临床治疗高血压动脉硬化采用阿托伐他汀效果显著,能有效缓解患者临床症状,改善血压情况,具有较高的临床应用价值。 Objective To analyze the clinical characteristics and effect of atorvastatin in the treatment of arteriosclerosis in elder patients with hypertension. Methods a retrospective analysis of the clinical data of 160 cases of hypertensive arteriosclerosis patients admitted to our hospital during June 2015-2016 during June, and were randomly divided into observation group and control group, with 80 cases of conventional treatment of patients for the control group, 80 cases were treated with routine therapy of atorvastatin treatment were divided into observation group, compared the treatment effect of two groups. Results After the treatment, the patients in the observation group the total efficiency is significantly higher than the control group(P<0.05), the improvement of blood pressure was significantly better than the control group(P<0.05). Conclusion: the clinical treatment of hypertensive arteriosclerosis with atorvastatin has significant effect, can effectively relieve clinical symptoms, improve blood pressure, with a high clinical value.
作者 薛晓龙
出处 《智慧健康》 2017年第5期121-123,共3页 Smart Healthcare
关键词 阿托伐他汀 高血压 动脉硬化 临床效果 特点 Atorvastatin hypertension arteriosclerosis clinical effect characteristic
  • 相关文献

参考文献7

二级参考文献47

  • 1蔡建萍.护理程序在老年高血压患者健康教育中的应用[J].齐鲁护理杂志,2004,10(7):546-546. 被引量:16
  • 2李华,徐香荷.影响社区老年高血压患者的因素分析及健康教育[J].现代中西医结合杂志,2006,15(10):1415-1416. 被引量:2
  • 3陈影珠,林果为.实用内科学[M].第13版.北京:人民卫生出版社,2009.
  • 4Michael J, Detkea M D, Yill L, et al. Duloxetine 60rag once daily dosing versus placebo in the acute treatment of major depression[J]. Journal of Psychiatric Research, 2002, 36(6): 383.
  • 5Borgh C, Domai A, Veronesi M, et al. Use of lipid lowering drug and blood pressure control in patients with arterial hypertension[J]. Clin Hypertens, 2002, 4: 1.
  • 6Lament S, Cockcroft J, van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications [J]. Eur Heart J, 2006, 27(21) : 2588.
  • 7Sugawara J, Hayashi K, Yokoi T, et al. Brachial - ankle pulse wave velocity: an index of central arterial stiffness[J]. Hum Hypertens, 2005, 19(5): 401.
  • 8Asmar R, Rudnichi A, Blaeher J, et al. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations [ J ] . Am J Hypertans, 2001, 14 (3) : 91297.
  • 9Vanderlinde N A, Sijbrands E J, Boomsma F, et al. Effect of low - density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin [J]. Hypertention, 2006, 47(6): 1125.
  • 10Michael J, Detkea MD, Yill L, et aI. Duloxetine 60mg oncedaily dosing versos phceho in the acute treaUnent of major depression[J]. J Psychiatric Rearch, 2002, 36(6): 383.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部